Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion

被引:47
作者
Duncker, DJ
Bache, RJ
机构
[1] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA
[2] Erasmus Univ, Thoraxctr, Lab Expt Cardiol, NL-3000 DR Rotterdam, Netherlands
关键词
blood flow; exercise; ischemia; microcirculation; resistance vessels; stenosis;
D O I
10.1016/S0163-7258(99)00074-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ischemia generally has been assumed to cause maximal vasodilation of the coronary resistance vessels. However, recent observations have demonstrated that during ischemia, the coronary microvessels can retain some degree of vasodilator reserve and remain responsive to vasoconstrictor stimuli. Traditional understanding of coronary blood now regulation envisioned an array of resistance vessels that respond homogeneously to local myocardial metabolic needs. Although coronary arterioles (<100 mu m) do respond to myocardial metabolic activity, recent studies have demonstrated that up to 40% of total coronary resistance resides in small arteries 100-400 mu m in diameter, Vasoconstriction of these small arteries is capable of decreasing blood flow, but they are minimally responsive to the metabolic effects of the resultant flow reduction. The lack of metabolic vasoregulation of the resistance arteries explains, at least in part, the observation that myocardial ischemia does not predictably cause maximal resistance vessel dilation. In addition, vasoconstrictor influences can compete with metabolic vasodilator activity in coronary arterioles. These findings suggest that pharmacologic vasodilators acting at the microvascular level might be therapeutically useful in patients with ischemic heart disease. Unfortunately, when myocardial ischemia results from a flow-limiting coronary stenosis, nonselective pharmacologic vasodilation of the resistance vessels can worsen subendocardial ischemia by decreasing intravascular pressure to produce coronary steal and by worsening of stenosis severity. Selective dilation of small arteries in ischemic regions might have potential for enhancing blood now. A critical property of an effective agent is that it not interfere with metabolic vasoregulation at the arteriole level, so that dilation of small arteries in adequately perfused regions would be countered by compensatory vasoconstriction of the arterioles to prevent coronary steal. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:87 / 110
页数:24
相关论文
共 210 条
[31]   FUNCTIONAL DISTRIBUTION OF ALPHA-ADRENERGIC AND ALPHA-2-ADRENERGIC RECEPTORS IN THE CORONARY MICROCIRCULATION [J].
CHILIAN, WM .
CIRCULATION, 1991, 84 (05) :2108-2122
[32]   REDISTRIBUTION OF CORONARY MICROVASCULAR RESISTANCE PRODUCED BY DIPYRIDAMOLE [J].
CHILIAN, WM ;
LAYNE, SM ;
KLAUSNER, EC ;
EASTHAM, CL ;
MARCUS, ML .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :H383-H390
[33]   CORONARY MICROVASCULAR RESPONSES TO REDUCTIONS IN PERFUSION-PRESSURE - EVIDENCE FOR PERSISTENT ARTERIOLAR VASOMOTOR TONE DURING CORONARY HYPOPERFUSION [J].
CHILIAN, WM ;
LAYNE, SM .
CIRCULATION RESEARCH, 1990, 66 (05) :1227-1238
[34]   HETEROGENEOUS MICROVASCULAR CORONARY ALPHA-ADRENERGIC VASOCONSTRICTION [J].
CHILIAN, WM ;
LAYNE, SM ;
EASTHAM, CL ;
MARCUS, ML .
CIRCULATION RESEARCH, 1989, 64 (02) :376-388
[35]   MICROVASCULAR PRESSURES AND RESISTANCES IN THE LEFT-VENTRICULAR SUBEPICARDIUM AND SUBENDOCARDIUM [J].
CHILIAN, WM .
CIRCULATION RESEARCH, 1991, 69 (03) :561-570
[36]   MICROVASCULAR DISTRIBUTION OF CORONARY VASCULAR-RESISTANCE IN BEATING LEFT-VENTRICLE [J].
CHILIAN, WM ;
EASTHAM, CL ;
MARCUS, ML .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (04) :H779-H788
[37]   EFFECTS OF ENDOTHELIN ON THE CORONARY VASCULAR BED IN OPEN-CHEST DOGS [J].
CLOZEL, JP ;
CLOZEL, M .
CIRCULATION RESEARCH, 1989, 65 (05) :1193-1200
[38]   INFLUENCE OF LOW PERFUSION-PRESSURE ON EFFECT OF ENDOTHELIN ON CORONARY VASCULAR BED [J].
CLOZEL, JP ;
SPRECHER, U .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :H893-H901
[39]   ENDOTHELIUM-DEPENDENT RELAXATION OF CORONARY-ARTERIES BY NORADRENALINE AND SEROTONIN [J].
COCKS, TM ;
ANGUS, JA .
NATURE, 1983, 305 (5935) :627-630
[40]  
COHEN RA, 1986, J PHARMACOL EXP THER, V237, P548